Literature DB >> 18794499

Double-blind, placebo-controlled, pilot trial of botulinum toxin A in restless legs syndrome.

Fatta B Nahab1, Elizabeth L Peckham, Mark Hallett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18794499      PMCID: PMC2676942          DOI: 10.1212/01.wnl.0000325994.93782.a1

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  6 in total

Review 1.  Why do restless legs occur at rest?--pathophysiology of neuronal structures in RLS. Neurophysiology of RLS (part 2).

Authors:  C Trenkwalder; W Paulus
Journal:  Clin Neurophysiol       Date:  2004-09       Impact factor: 3.708

2.  Can botulinum toxin put the restless legs syndrome to rest?

Authors:  Erle C H Lim; Raymond C S Seet
Journal:  Med Hypotheses       Date:  2007-03-23       Impact factor: 1.538

3.  Efficacy and safety of pramipexole in restless legs syndrome.

Authors:  J W Winkelman; K D Sethi; C A Kushida; P M Becker; J Koester; J J Cappola; J Reess
Journal:  Neurology       Date:  2006-08-23       Impact factor: 9.910

4.  Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome.

Authors:  Arthur S Walters; Cheryl LeBrocq; Anjana Dhar; Wayne Hening; Ray Rosen; Richard P Allen; Claudia Trenkwalder
Journal:  Sleep Med       Date:  2003-03       Impact factor: 3.492

5.  Successful treatment of recalcitrant restless legs syndrome with botulinum toxin type-A.

Authors:  Joshua S Rotenberg; Kevin Canard; Marc Difazio
Journal:  J Clin Sleep Med       Date:  2006-07-15       Impact factor: 4.062

Review 6.  Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group.

Authors:  A S Walters
Journal:  Mov Disord       Date:  1995-09       Impact factor: 10.338

  6 in total
  4 in total

1.  Restless legs syndrome: pathophysiology and treatment.

Authors:  William G Ondo
Journal:  Curr Treat Options Neurol       Date:  2014-11       Impact factor: 3.598

Review 2.  Use of Botulinum Neurotoxin in Parkinson's Disease: A Critical Appraisal.

Authors:  Wolfgang H Jost
Journal:  Toxins (Basel)       Date:  2021-01-25       Impact factor: 4.546

Review 3.  Botulinum Toxin in Movement Disorders: An Update.

Authors:  Charenya Anandan; Joseph Jankovic
Journal:  Toxins (Basel)       Date:  2021-01-08       Impact factor: 4.546

4.  Botulinum Toxin in Restless Legs Syndrome-A Randomized Double-Blind Placebo-Controlled Crossover Study.

Authors:  Shivam Om Mittal; Duarte Machado; Diana Richardson; Divyanshu Dubey; Bahman Jabbari
Journal:  Toxins (Basel)       Date:  2018-09-29       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.